North America

Royal Bank of Scotland was selling new senior unsecured bonds in the dollar market on Tuesday, building on a series of success prints from European financial institutions.

Bank of America Merrill Lynch dropped its issuance forecast for this year by $20bn on Monday, in the middle of what is usually the busiest month in the primary market calendar for US high yield bonds.

CME Group on Monday launched two new indices to calculate the price of ether, the second most popular cryptocurrency after bitcoin by market capitalisation.

GlobalCapital is pleased to announce the winners for this year’s Americas Derivatives Awards. The results were announced at a gala dinner at the Metropolitan Club in New York on Thursday. The awards honour the firms and innovations that have pushed the derivatives market forward over the last 12 months.

BMW Finance had to negotiate its way through a busy corporate bond market on Monday as it sold a €1.75bn 4.5 and eight year dual tranche offering. It had to pay new issue premiums of around 8bp-10bp but saw strong demand.

Two A-rated corporates went head to head in the euro corporate bond market on Monday as UK pharmaceutical giant GlaxoSmithKline and US electrical systems manufacturer United Technologies Corp both launched triple-tranche deals, with two matching maturities, which totalled €4.5bn.

Texan chemicals group Kraton opened up the European high yield deal pipeline this week with a debut deal that will help refinance a dollar bond. The firm is also topping up a US loan as it looks to cut its borrowing costs.

Taiwan-based M17 Entertainment, a web streaming platform, has filed for a $115m IPO on the New York Stock Exchange.

Huya, a live streaming platform backed by YY and Tencent, has raised $180m after pricing its US IPO at the top of guidance.

HSBC took home $6bn from a callable bond issuance on Thursday, after Barclays opened the callable market for jumbo Yankee issuers earlier in the week.

The Futures Industry Association on Thursday broadly endorsed the need for mechanisms that help deal with extreme volatility on trading venues, arguing that there shouldn't be a "one-size-fits-all" approach.

GlaxoSmithKline added to the crush of red hot dollar bond supply this week, as borrowers began a spring stampede to lock in funding ahead of a likely rate rise next month.